Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 10,432 | 11,318 | 14,799 | 9,317 | 78,842 |
| Operating Income | -10,432 | -11,318 | -14,799 | -9,317 | -78,842 |
| Interest Expense | 124 | 139 | 125 | 122 | 105 |
| Other Income | 10 | 10 | 10 | 269 | -284 |
| Pre-tax Income | -10,546 | -11,447 | -14,914 | -9,170 | -79,231 |
| Net Income Continuous | -10,546 | -11,447 | -14,914 | -9,170 | -79,231 |
| Net Income | $-10,546 | $-11,447 | $-14,914 | $-9,170 | $-79,231 |
| EPS Basic Total Ops | -0.28 | 2.27 | -0.40 | -0.25 | -5.22 |
| EPS Basic Continuous Ops | -0.28 | 2.27 | -0.40 | -0.25 | -5.22 |
| EPS Diluted Total Ops | -0.28 | 2.27 | -0.40 | -0.25 | -5.22 |
| EPS Diluted Continuous Ops | -0.28 | 2.27 | -0.40 | -0.25 | -5.22 |
| EBITDA(a) | $-10,378 | $-11,259 | $-14,747 | $-9,266 | $-78,826 |